TETRANITE for Dental Implant Stabilization
Immediate placement and stabilization of dental implants
Key Facts
About RevBio
RevBio is pioneering the first synthetic bone adhesive with its TETRANITE platform, a bioinspired biomaterial that functions as both a fixation device and a scaffold for bone regeneration. The company's lead program is in a first-in-human clinical trial for cranial flap fixation, supported by a $2.4 million NIH grant, and it has a pipeline targeting significant opportunities in dental stabilization, dental bone grafting, and orthopedics. As a private, pre-revenue company, RevBio's technology addresses a long-standing unmet need in surgery, potentially replacing metal hardware with a resorbable adhesive that improves healing outcomes and reduces procedure complexity across multiple surgical specialties.
View full company profile